Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
Event Date |
Tue Mar 12 CET - Wed Mar 13 CET (9 months ago)
In your timezone (EST): Mon Mar 11 7:00pm - Tue Mar 12 7:00pm |
Location |
Amsterdam RAI
Europaplein 24, 1078 GZ Amsterdam, Netherlands |
Region | EMEA |
World Leading Healthcare Evidence, Pricing and Access Congress.
2024 Speakers
Omar Ali
Visiting Lecturer, VBA & Former Advisor, NICE, University of Portsmouth
Herbert Altmann
Head of Market Access, Pricing and Reimbursement Europe, Cencora Pharmalex
Luigi Angelillo
Director, Market Access EMEA, Argenx
Ad Antonisse
Director, Market Access & External Affairs, AstraZeneca
Jose Aragunde
Value and Pricing Strategy Lead, Market Access, Novartis
Diego Ardigò
Global Rare Disease, Research & Development Head & Executive Board Member and Vice Chair, Chiesi Group & EUCOPE
Jorge Arellano
Vice President, Head of Intercontinental Markets, Market Access, Pricing, & Value Demonstration, Bristol Myers Squibb
Marnix Artz
Head Patient Access, Pricing & Governmental Affairs, Merck Group
Nico Bacharidis
Chief Commercial Officer, Cube RM
Johnny Bane
Head of Market Access, Accord Healthcare
Sylvaine Barbier
Principal, RWE & Biostatistics, Putnam
Alexander Bastian
Advisor, Market Access, A.M. Pharma & Memo Therapeutics
Dianne Baunbaek
Precision Medicine Lead, Janssen Pharmaceutical
Ahmad Bechara
Executive Vice President, Pharma, Alira Health
Tomer Ben Zaken
Head of Commercial Operations & Trade, Astellas
Katja Berg
Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU, AstraZeneca
Rito Bergemann
Vice President, Health Economics and Outcomes Research, Parexel
Nick Besseling
Manager, Value Strategies & Agreements, AstraZeneca
Ingrid Bettum
Senior Advisor, Norwegian Medicines Agency
Chris Bidad
Global Head, Access Strategy and Payer Policy, AstraZeneca
Matthias Bischof
Senior Director, Global Health Economics, Novartis Gene Therapies
Jesper Bjerggren
Associate Director, European Market Access, Teva Pharmaceuticals
Marie-Sharmila Blandino
Director, Global Access Strategy Lead, Amgen
Par Bolina
Adjunct Associate Professor, Medicinal Chemistry, Rutgers university
Thomas Bols
Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics
Kinga Borsos
Vice President, HEOR, Boehringer Ingelheim
Anh Bourcet (Nguyen)
Strategic Advisor, Market Access Leader, APACMed, Asia Pacific Medical Technology Association
Vidya Breeveld
Independent Market Access Expert
Jennifer Bright
President, ICHOM
Sangeeta Budhia
Vice President, Pricing & Market Access, Parexel
Robert Burley
Director, Care, Campaigns and Support, The Muscular Dystrophy U.K.
Hatice Camdere
Executive Director, Value, Access & Policy, Amgen
Gorana Capkun
Vice President, Global Head of Patient Focused Real World Evidence, Merck Group
Lorenzo Capretto
Market Access Lead EU&EM, Global Rare Disease, Chiesi Farmaceutici SpA
Sandro Cesaro
Head of Europe Market Access & Pricing, AstraZeneca
François-Xavier Chalet
Associate Director, Health Economics Expert, Idorsia Pharmaceutical Ltd.
Catherine Chamoux
Principal, AESARA
José Luis Sánchez Chorro
Director, Market Access, Spain and Portugal, Jazz Pharmaceuticals
Sally Chung
Vice President, Head of Market Access & Pricing Europe, GSK
Paolo Correale
Senior Principal, Global Pricing & Access Consulting, Eversana
Paolo Angelo Cortesi
Assistant Professor in Public Health, Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.
Elisa Crovato
Director, Pricing & Market Access, Chiesi Group
Alan Crowther
General Manager, Global Pricing & Access, Eversana
Marcus Dahlman
Head of Market Access Europe, Hansa Biopharma
Nidhi Dani
Director, Global Market Access, Novartis
Adrien De Montgolfier
Global Pricing Analyst, Ferring
Emanuele Degortes
Vice President, Global Head of Access Policy and Patient Advocacy, Menarini
Rossella Di Bidino
Head of HTA for AI Unit, Graduate School of Health Economics and Management ALTEMS
Toon Digneffe
Head, Public Affairs & Public Policy, Europe & Canada, Takeda
Riad Dirani
Vice President, Global HEOR, Medical Operations & Excellence, Teva Pharmaceuticals
Patricia Dorling
Head, Global HEOR and Real World Evidence, Chiesi Group
Ahmed Edathodu
Founding Director, Access Infinity Ltd
Ruven Remo Eul
Principal, Life Sciences, Marbls
Joanne Evason
Partner, Putnam
Gina Ewy
VP, Head of Global Market Access, Hansa Biopharma
Marina Faiella
Head, Forecasting and Business Analytics, Europe, BeiGene
Peter Fassler
Director, Market Access, Gilead Sciences
Diar Fattah
Director, Health Economics and Outcomes Research, Vertex Pharmaceuticals
Sarah Ferry
Senior Policy Advisor, Innovation & Life Sciences, NHS Confederation
Stefaan Fiers
Head of Corporate Communication, Public Affairs & Patient Advocacy, Belgium, Takeda
Lora Fleifel
Director, Market Access Operations, Oncology Europe, Merck
Graham Foxon
Managing Director, Remap Consulting
Neil Gallagher
Managing Economist, Copenhagen Economics
Benjamin Gannon
Vice President, International, Guardant Health
Sonia García Pérez
HTACG representative. Head of international affairs., AEMPS
Suzanne Gaunt
Chief Executive Officer, Your Advisor
Alexander Gee
Senior Director, Customer Strategy, Parexel
Fabrizio Gianfrate
Full Professor, Health Economics and Outcomes Research, Former AIFA
Jonathan Gibson
Market Access Consultant, Initiate Consultancy
Ramiro Gilardino
Senior Director, Global HTA & Access Policy Lead, MSD
Thomas Gilboy
Product Owner, Access Infinity
Christoph Glaetzer
Chief Global Value and Access Officer, Johnson & Johnson
Tristan Gloede
Executive Director, Global Head of Market Access Retinal Health, Boehringer Ingelheim
Josie Godfrey
Co-Chief Executive Officer, Realise Advocacy
Maja Graf
Associate Director, Policy & Market Access, Medicines for Europe
Ingolf Griebsch
Global Head, Health Economics & Outcome Research, Ferring Pharmaceuticals
Thomas Grub
Senior Expert, Global Pricing and Market Access, medac GmbH
Neil Grubert
Global Market Access Consultant, Independent
Josep Maria Guiu Segura
Director, Pharmacy and Medicines Area, Consortium of health and social care of Catalonia
Marlene Gyldmark
Head Access Evidence, Idorsia
Janice Haigh
Practice Lead, Remap Consulting
Matthew Hanchard
Research Fellow, University of Sheffield
Günter Harms
Senior Director, Patient Access, Germany, Austria, Switzerland, Novartis Gene Therapies
Adrian Harrington
Senior Director, Value & Access, Biogen
Hugo Hayes
Manager, Putnam
Alison Horsfield
Director, Global Access Strategy, Astrazeneca
Kirsty Hoyle
CEO, Metabolic Support UK
Tijana Ignjatovic
Executive Director, Genesis Research Group
Giorgio Iotti
Head Of Program Leadership And Control, Rare Disease Unit, Chiesi Farmaceutici SpA
Dawn Ireland
President & Founder, CDH International
Khalid Ismail
Senior Manager, Market Access Benelux, CSL Behring
Shrividya Iyer
Principal, Putnam Associates
Jayasree Iyer
Chief Executive Officer, Access to Medicine Foundation
Daniel Jackson
Global Head, Market Access Policy, UCB
Saira Jan
Vice-President & Chief Pharmacy Officer, Blue Cross Blue Shield of New Jersey
Rosemary Jose
Executive Director, Market Access & HEOR, OPEN Health
Madhu Kabra
Global Director, Health Economics and Outcomes Research, MKGlobal
Lisette Kaskens
Director, Market Access, Europe, LATAM & Canada, Ferring Pharmaceuticals
Sebastian Kessel
Senior Director, Head of Market Access & External Engagement Germany, UCB
Rob Kettell
Director, Commercial Medicines Negotiation and Complex Transactions, NHS England
Elizabeth Kinter
Vice President, Head of Evidence, Value and Access, Vir Biotechnology
Sandeep Kiri
Global Head, Health Economics and HTA Evidence, Ucb
Lori Klein
Partner, Medical & Scientific Affairs Practice Lead, Putnam
Jolanda Koenders
Head of New Product Planning, Central Southeast Europe, Takeda
Hannah Kurth
Founder, PULSEdge
Lydia Lanman
Director, Global Policy, Roche
Marianne Laouri
Executive Director, Value Demonstration, Specialty Products & Quality of Care, Boehringer Ingelheim
Agathe Le Lay
Vice President, Head of Global Value Evidence & Patient Insights, Medical Affairs, H. Lundbeck A/S
Colombe Le Rudulier
Senior Consultant, Life Sciences, Marbls
Katja Lundell
Senior Director, Global Head of Pricing, Access and Communications, theramex
Elena Lungu
Manager of Policy Development, Patented Medicine Prices Review Board, Government of Canada
Manuela Machado
Head, Global Payer Strategy Solutions, Ucb
Jörg Mahlich
Market Access and Government Affairs Lead, Milteny
Charles Makin
Head, RWE and Epi, Boehringer Ingelheim
Farzana Malik
Independent Market Access Expert
Chris Mancill
Senior Vice President, Head, Global Market Access, Pricing, and Value Demonstration, Bristol Myers Squibb
Lorenzo Mantovani
Professor of Public Health, University Of Milano - Bicocca
Andrea Mantovani
VP & Partner, Consulting (Value, Access & Pricing), Alira Health
Anne Marciniak
Market Access and Health Economics Executive, Adelphi Values
Silvy Mardiguian
Senior Director, Head of HEOR, Europe & New Markets, BeiGene
Francesco Marinucci
Director, Global Market Access, Abbott
Jake McDowell
Vice President, Head of Market Access and Pricing, Partner Therapeutics
Vivian Mendonca
Senior Vice President, Global Head, Market Access, Pricing, HEOR and External Affairs, MENARINI GROUP
Magnus Meyer
Global Pricing & Market Access Manager, Lundbeck
Erin Mistry
Executive Vice President, Chief Commercial Officer, CorMedix Inc
Leyla Mohseninejad
Director, BeiGene
Lorenzo Montrasio
Former Senior Scientific Officer, Council of Europe
Paolo Morgese
Head of Public Affairs, Europe, Alliance for Regenerative Medicine
Christine Mossa
Vice President, Global Value & Access, Neuroscience, Ipsen Biopharmaceuticals Canada Inc.
Michael Mueller
Head Of Market Access, Western Europe, Sun Pharma
Neil Mulcock
Vice President, International Government Affairs and Policy, Gilead Sciences
Andrew Mumford
Chief Executive Officer, Initiate Consultancy
Bogdan Muresan
Director, Global HEOR, Astellas Pharma
Katrin Nather
•
Associate Director, Genesis Research Group
Alexander Natz
Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs
Emilie Neez
Director, Dolon
Claudia Neuber
Head of Global Pricing, Oncology, AstraZeneca
Eric Noehrenberg
Global Vice President, Market Access and Government Affairs, CORCYM
Esther Nzenza, Chief Executive Officer & Founder, DECISIVE CONSULTING LTD
Andrew Olaye
Executive Director, Head of Market Access and Partnership EMEA, Orchard Therapeutics Ltd
Matias Olsen
Senior Manager, Public Affairs & Policy, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs
Melvin Olson
Founder, Olson Strategies, Olson Strategies GmbH
Donal O'Sullivan
Global Head, Market Access, Mundipharma
Loubna Ouriaghli
Head of Government Affairs and Policy, Ipsen
Gavin Outteridge
Managing Director, AESARA Europe
Ipek Ozer-Stillman,
Vice President, Global Head, Health Economics, Takeda
Casper Paardekooper
Partner, Vintura, Part of Cencora
Robert Palmer
Head of Market Access, Oncology, Boehringer Ingelheim
Elena Panitti
Global Director, Evidence Valuation and Enablement, Novartis
Michela Pantaleoni
Chief Market Access Officer, Napo Therapeutics
2024 Sponsors
TITLE SPONSOR:
• Lifescience Dynamis
PLATINUM SPONSORS:
• PXA
• Parexel
• Access Infinity
• Alira Health
• Eversana
• Putnam Inizio Company
• Remap
• Valid Insight
GOLD SPONSORS:
• Cube
• Decisive Consulting
• Lyfegen
• Ernst & Young
• Generis Research Group
• Global Pricing Innovations
• MKT XS
• Precision Advisors
• Sentence Partners
•